Single-cell transcriptomic analysis of the tumor ecosystem of adenoid cystic carcinoma

Adenoid cystic carcinoma (ACC) is a malignant tumor that originates from exocrine gland epithelial cells. We profiled the transcriptomes of 49,948 cells from paracarcinoma and carcinoma tissues of three patients using single-cell RNA sequencing. Three main types of the epithelial cells were identifi...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 1063477
Main Authors Lin, Quanquan, Fang, Zhanjie, Sun, Jinlong, Chen, Fei, Ren, Yipeng, Fu, Zhenhong, Yang, Sefei, Feng, Lin, Wang, Feng, Song, Zhigang, Chen, Wei, Yu, Wenjun, Wang, Chen, Shi, Yixin, Liang, Yue, Zhang, Haizhong, Qu, Hongzhu, Fang, Xiangdong, Xi, Qing
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 17.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Adenoid cystic carcinoma (ACC) is a malignant tumor that originates from exocrine gland epithelial cells. We profiled the transcriptomes of 49,948 cells from paracarcinoma and carcinoma tissues of three patients using single-cell RNA sequencing. Three main types of the epithelial cells were identified into myoepithelial-like cells, intercalated duct-like cells, and duct-like cells by marker genes. And part of intercalated duct-like cells with special copy number variations which altered with MYB family gene and EN1 transcriptomes were identified as premalignant cells. Developmental pseudo-time analysis showed that the premalignant cells eventually transformed into malignant cells. Furthermore, MYB and MYBL1 were found to belong to two different gene modules and were expressed in a mutually exclusive manner. The two gene modules drove ACC progression into different directions. Our findings provide novel evidence to explain the high recurrence rate of ACC and its characteristic biological behavior.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Ester Orlandi, National Center of Oncological Hadrontherapy, Italy
This article was submitted to Head and Neck Cancer, a section of the journal Frontiers in Oncology
These authors have contributed equally to this work
Reviewed by: Yingying Jiang, Affiliated Hospital of Weifang Medical University, China; Gennaro Gambardella, Telethon Institute of Genetics and Medicine (TIGEM), Italy
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.1063477